chartexchange

PBYI
PUMA BIOTECHNOLOGY INC
stockNASDAQ

At CloseNov 18, 2026 3:59:56 PM EST
7.23USD+1.261%(+0.09)454,066
Pre-marketNov 18, 2026 8:22:30 AM EST
7.50USD+5.042%(+0.36)
After-hoursNov 18, 2026 4:00:30 PM EST
7.22USD-0.138%(-0.01)
Loading…
Loading…
373.78M
Healthcare
Biotechnology
HQ
Los Angeles, CA, USA
Previous Close
$7.14
Beta
0.98
52-Week High
$11.50 2026-10-23
52-Week Low
$4.80 2025-11-20
SMA 50
$9.63
SMA 200
$8.04
Avg. Vol 10D
597,079
Avg. Vol 30D
444,563
Avg. Vol 90D
360,505
Relative Vol
1.02
40.14M
0.4100%
1,500,000
7,961
PBYI Profile

we focus on in-licensing innovative drug candidates that are undergoing or have already completed initial clinical testing for the treatment of various forms of cancer and then seek to further develop these drug candidates for commercial use.

PBYI Performance
PeriodPriceDateChangeBeta
1W8.082026-11-12-10.52%2.700
1M10.212026-10-19-29.19%1.334
3M9.492026-08-19-23.82%1.270
6M6.812026-05-19+6.17%0.701
1Y4.892025-11-19+48.00%0.978
2Y2.742024-11-19+163.87%—
5Y3.422021-11-19+111.40%0.985
PBYI Stock Summary

PUMA BIOTECHNOLOGY INC (NASDAQ:PBYI) stock price today is $7.23, and today's volume is 454,066. PBYI is up 1.261% today. The 30 day average volume is 444,563. PBYI market cap is $373.78M with 51.70M shares outstanding.